Safety of add-on sulfonylurea therapy in patients with type 2 diabetes using metformin: a population-based real-world study
Ogunremi OO, Ismail SF, Dhami RK, Newton JS, Kindle SA, Kozmenko V
Your body was just getting comfortable at the lower dose, and now you are asking it to handle twice as much
Singh reviewed the latest evidence examining GLP-1 therapies in relation to diabetic retinopathy (DR), age-related macular degeneration (AMD), nonarteritic anterior ischemic optic neuropathy (NAION), and retinal vein occlusion (RVO)
Taiyuan: Shanxi Medical University
What research exists on GHK-Cu and skin elasticity